Author

Yu-Ling Yang

Masonic Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Adam J. DupuyiD· 1 shared Adam L. BurrackiD· 1 shared Alex T. LarssoniD· 1 shared Alexander K. TsaiiD· 1 shared Branden S. MoriarityiD· 1 shared Brooke L. KimballiD· 1 shared Carli M. StewartiD· 1 shared Chang-Jung LeeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adam J. DupuyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sleeping Beauty mutagenesis identifies BACH2 and other regulators of CD8+T cell exhaustion, persistence in vivo, and CAR-T function under tumor-associated chronic antigen stimulation

Chang-Jung Lee, Alex T. Larsson, Tyler A. Jubenville, Wendy A. Hudson, Zachary J. Seeman, Carli M. Stewart, Alexander K. Tsai, Adam L. Burrack, Brooke L. Kimball, Elizabeth L. Siegler, Vianca V. Vianzon, Erin E. Nolan, Yu-Ling Yang, Christopher M. Stehn, Daryl M. Gohl, , David A. Largaespada

The paper uses Sleeping Beauty mutagenesis to identify BACH2 and other genes that enhance CD8+ T cell persistence and function under chronic antigen stimulation, improving engineered T cell therapies.

Journal for ImmunoTherapy of Cancer · Jul 1, 2026Peer-reviewedImmunology